CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 706 of 870
Non-Antibody Products
Page 706 of 870
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Retro-2 | A selective inhibitor of retrograde protein trafficking mediated by syntax… | 1 mg | 21946-1 | More Info |
| Retro-2 | A selective inhibitor of retrograde protein trafficking mediated by syntax… | 10 mg | 21946-10 | More Info |
| Retro-2 | A selective inhibitor of retrograde protein trafficking mediated by syntax… | 25 mg | 21946-25 | More Info |
| Retro-2 | A selective inhibitor of retrograde protein trafficking mediated by syntax… | 5 mg | 21946-5 | More Info |
| Reuterin | A bacterial glycerol metabolite with antibacterial activity; is produced b… | 100 mg | 36300-100 | More Info |
| Reuterin | A bacterial glycerol metabolite with antibacterial activity; is produced b… | 25 mg | 36300-25 | More Info |
| Reuterin | A bacterial glycerol metabolite with antibacterial activity; is produced b… | 250 mg | 36300-250 | More Info |
| Reuterin | A bacterial glycerol metabolite with antibacterial activity; is produced b… | 50 mg | 36300-50 | More Info |
| REV 5901 | REV 5901 is an antagonist of cysteinyl-leukotriene receptors with a Ki val… | 10 mg | 70600-10 | More Info |
| REV 5901 | REV 5901 is an antagonist of cysteinyl-leukotriene receptors with a Ki val… | 100 mg | 70600-100 | More Info |
| REV 5901 | REV 5901 is an antagonist of cysteinyl-leukotriene receptors with a Ki val… | 5 mg | 70600-5 | More Info |
| REV 5901 | REV 5901 is an antagonist of cysteinyl-leukotriene receptors with a Ki val… | 50 mg | 70600-50 | More Info |
| Reveromycin A | A spiroketal antibiotic that inhibits EGF mitogenic activity, displays ant… | 1 mg | 17458-1 | More Info |
| Reveromycin A | A spiroketal antibiotic that inhibits EGF mitogenic activity, displays ant… | 250 µg | 17458-250 | More Info |
| Reveromycin B | A bacterial metabolite; inhibits EGF-induced mitogenic activity in Balb /… | 1 mg | 25481-1 | More Info |
| Reveromycin B | A bacterial metabolite; inhibits EGF-induced mitogenic activity in Balb /… | 250 µg | 25481-250 | More Info |
| Reveromycin C | A polyketide with antifungal activity against C. albicans (MICs = 2.0 and… | 1 mg | 23488-1 | More Info |
| Reveromycin C | A polyketide with antifungal activity against C. albicans (MICs = 2.0 and… | 250 µg | 23488-250 | More Info |
| Reveromycin D | A bacterial metabolite; inhibits EGF-induced mitogenic activity in Balb /… | 1 mg | 28101-1 | More Info |
| Reveromycin D | A bacterial metabolite; inhibits EGF-induced mitogenic activity in Balb /… | 250 µg | 28101-250 | More Info |
| Reversin 121 | A hydrophobic peptide chemosensitizer that reverses P-glycoprotein-mediate… | 1 mg | 18603-1 | More Info |
| Reversin 121 | A hydrophobic peptide chemosensitizer that reverses P-glycoprotein-mediate… | 5 mg | 18603-5 | More Info |
| Reversin 121 | A hydrophobic peptide chemosensitizer that reverses P-glycoprotein-mediate… | 500 µg | 18603-500 | More Info |
| Reversine | A purine derivative; induces differentiation or dedifferentiation, dependi… | 1 mg | 10004412-1 | More Info |
| Reversine | A purine derivative; induces differentiation or dedifferentiation, dependi… | 10 mg | 10004412-10 | More Info |
| Reversine | A purine derivative; induces differentiation or dedifferentiation, dependi… | 25 mg | 10004412-25 | More Info |
| Reversine | A purine derivative; induces differentiation or dedifferentiation, dependi… | 5 mg | 10004412-5 | More Info |
| RF9 | An NPFF receptor antagonist; binds to human NPFF1 and NPFF2 receptors (Kis… | 1 mg | 31412-1 | More Info |
| RF9 | An NPFF receptor antagonist; binds to human NPFF1 and NPFF2 receptors (Kis… | 10 mg | 31412-10 | More Info |
| RF9 | An NPFF receptor antagonist; binds to human NPFF1 and NPFF2 receptors (Kis… | 5 mg | 31412-5 | More Info |
| R-(-)-Flecainide | An antiarrhythmic agent; prevents chloroform-induced ventricular fibrillat… | 1 mg | 20682-1 | More Info |
| R-(-)-Flecainide | An antiarrhythmic agent; prevents chloroform-induced ventricular fibrillat… | 500 µg | 20682-500 | More Info |
| (R)-5-fluoro ADB | An analytical reference standard categorized as a synthetic CB; regulated… | 1 mg | 16603-1 | More Info |
| (R)-5-fluoro ADB | An analytical reference standard categorized as a synthetic CB; regulated… | 10 mg | 16603-10 | More Info |
| (R)-5-fluoro ADB | An analytical reference standard categorized as a synthetic CB; regulated… | 5 mg | 16603-5 | More Info |
| (R)-Flurbiprofen | A COX-inactive enantiomer of flurbiprofen; inhibits γ-secretase acti… | 1 g | 70255-1 | More Info |
| (R)-Flurbiprofen | A COX-inactive enantiomer of flurbiprofen; inhibits γ-secretase acti… | 100 mg | 70255-100 | More Info |
| (R)-Flurbiprofen | A COX-inactive enantiomer of flurbiprofen; inhibits γ-secretase acti… | 250 mg | 70255-250 | More Info |
| (R)-Flurbiprofen | A COX-inactive enantiomer of flurbiprofen; inhibits γ-secretase acti… | 500 mg | 70255-500 | More Info |
| RG108 | A non-nucleoside DNA methyltransferase inhibitor (IC50 = 115 nM in vitro)… | 10 mg | 13302-10 | More Info |
| RG108 | A non-nucleoside DNA methyltransferase inhibitor (IC50 = 115 nM in vitro)… | 100 mg | 13302-100 | More Info |
| RG108 | A non-nucleoside DNA methyltransferase inhibitor (IC50 = 115 nM in vitro)… | 5 mg | 13302-5 | More Info |
| RG108 | A non-nucleoside DNA methyltransferase inhibitor (IC50 = 115 nM in vitro)… | 50 mg | 13302-50 | More Info |
| RG-13022 | An inhibitor of EGF receptor kinase (IC50 = 1 µM in HT-22 cells) | 10 mg | 10010309-10 | More Info |
| RG-13022 | An inhibitor of EGF receptor kinase (IC50 = 1 µM in HT-22 cells) | 5 mg | 10010309-5 | More Info |
| RG-13022 | An inhibitor of EGF receptor kinase (IC50 = 1 µM in HT-22 cells) | 50 mg | 10010309-50 | More Info |
| RG-14620 | An inhibitor of EGF receptor kinase (IC50 = 3 µM in HT-22 cells) | 10 mg | 10010310-10 | More Info |
| RG-14620 | An inhibitor of EGF receptor kinase (IC50 = 3 µM in HT-22 cells) | 5 mg | 10010310-5 | More Info |
| RG-14620 | An inhibitor of EGF receptor kinase (IC50 = 3 µM in HT-22 cells) | 50 mg | 10010310-50 | More Info |
| RG3039 | A DcpS inhibitor (IC50 = 0.069 nM); prevents denervation of the NMJ and de… | 1 mg | 36589-1 | More Info |
| RG3039 | A DcpS inhibitor (IC50 = 0.069 nM); prevents denervation of the NMJ and de… | 10 mg | 36589-10 | More Info |
| RG3039 | A DcpS inhibitor (IC50 = 0.069 nM); prevents denervation of the NMJ and de… | 25 mg | 36589-25 | More Info |
| RG3039 | A DcpS inhibitor (IC50 = 0.069 nM); prevents denervation of the NMJ and de… | 5 mg | 36589-5 | More Info |
| RG-7090 | A negative allosteric modulator of mGluR5; binds to mGluR5 (Ki = 35.6 nM);… | 1 mg | 36806-1 | More Info |
| RG-7090 | A negative allosteric modulator of mGluR5; binds to mGluR5 (Ki = 35.6 nM);… | 10 mg | 36806-10 | More Info |
| RG-7090 | A negative allosteric modulator of mGluR5; binds to mGluR5 (Ki = 35.6 nM);… | 25 mg | 36806-25 | More Info |
| RG-7090 | A negative allosteric modulator of mGluR5; binds to mGluR5 (Ki = 35.6 nM);… | 5 mg | 36806-5 | More Info |
| RG-7112 | An inhibitor of the MDM2-p53 interaction (IC50 = 0.018 µM); inhibits… | 1 mg | 25673-1 | More Info |
| RG-7112 | An inhibitor of the MDM2-p53 interaction (IC50 = 0.018 µM); inhibits… | 10 mg | 25673-10 | More Info |
| RG-7112 | An inhibitor of the MDM2-p53 interaction (IC50 = 0.018 µM); inhibits… | 25 mg | 25673-25 | More Info |
| RG-7112 | An inhibitor of the MDM2-p53 interaction (IC50 = 0.018 µM); inhibits… | 5 mg | 25673-5 | More Info |
| RG7388 | A selective MDM2 inhibitor that blocks the binding of MDM2 to p53 (IC50 =… | 1 mg | 21532-1 | More Info |
| RG7388 | A selective MDM2 inhibitor that blocks the binding of MDM2 to p53 (IC50 =… | 10 mg | 21532-10 | More Info |
| RG7388 | A selective MDM2 inhibitor that blocks the binding of MDM2 to p53 (IC50 =… | 25 mg | 21532-25 | More Info |
| RG7388 | A selective MDM2 inhibitor that blocks the binding of MDM2 to p53 (IC50 =… | 5 mg | 21532-5 | More Info |
| (R)-γ-Valerolactone | An isomer of GVL, which is a prodrug to GHV; has potential for use as a bi… | 100 mg | 20837-100 | More Info |
| (R)-γ-Valerolactone | An isomer of GVL, which is a prodrug to GHV; has potential for use as a bi… | 250 mg | 20837-250 | More Info |
| (R)-γ-Valerolactone | An isomer of GVL, which is a prodrug to GHV; has potential for use as a bi… | 50 mg | 20837-50 | More Info |
| (R)-γ-Valerolactone | An isomer of GVL, which is a prodrug to GHV; has potential for use as a bi… | 500 mg | 20837-500 | More Info |
| RGB-286638 | A multi-kinase inhibitor; inhibits a variety of kinases, including CDK2-7… | 100 mg | 29499-100 | More Info |
| RGB-286638 | A multi-kinase inhibitor; inhibits a variety of kinases, including CDK2-7… | 250 mg | 29499-250 | More Info |
| RGB-286638 | A multi-kinase inhibitor; inhibits a variety of kinases, including CDK2-7… | 500 mg | 29499-500 | More Info |
| RGD Peptide (trifluoroacetate salt) | A synthetic compound made up of the arginine-glycine-aspartate motif used… | 1 mg | 14501-1 | More Info |
| RGD Peptide (trifluoroacetate salt) | A synthetic compound made up of the arginine-glycine-aspartate motif used… | 10 mg | 14501-10 | More Info |
| RGD Peptide (trifluoroacetate salt) | A synthetic compound made up of the arginine-glycine-aspartate motif used… | 25 mg | 14501-25 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile